1. Home
  2. XPON vs GTBP Comparison

XPON vs GTBP Comparison

Compare XPON & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expion360 Inc.

XPON

Expion360 Inc.

HOLD

Current Price

$0.68

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.31

Market Cap

8.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPON
GTBP
Founded
2016
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
8.8M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
XPON
GTBP
Price
$0.68
$0.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
168.4K
556.5K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
94.63
3.75
EPS
N/A
N/A
Revenue
$9,651,870.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
71.59
N/A
52 Week Low
$0.49
$0.26
52 Week High
$5.50
$3.73

Technical Indicators

Market Signals
Indicator
XPON
GTBP
Relative Strength Index (RSI) 46.61 35.43
Support Level $0.65 N/A
Resistance Level $0.84 $0.46
Average True Range (ATR) 0.06 0.03
MACD -0.01 -0.01
Stochastic Oscillator 15.34 35.32

Price Performance

Historical Comparison
XPON
GTBP

About XPON Expion360 Inc.

Expion360 Inc focuses on the design, assembly, manufacturing, and sale of lithium iron phosphate (LiFePO4) batteries and related accessories for RV, marine, and industrial applications. Its high-performance battery solutions are designed for high energy density and a compact footprint, supported by engineering and intellectual property to enhance safety, quality, and performance. The company also engages in product design, development, and collaboration to strengthen customer relationships. It serves dealers, wholesalers, private-label customers, and OEMs, who distribute its products to end consumers. Its segment is Energy Storage (ES), providing lithium-based energy solutions backed by durable materials, optimized internal structures, and responsive customer service.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: